Penicillin-susceptible and erythromycin-resistant Streptococcus pneumoniae in children with acute mastoiditis

F del Castillo1, F Ledesma, A García-Perea

  • 1Pediatric Infectious Disease Unit, Children's University Hospital La Paz, Madrid, Spain. fdm02m@nacom.es

Insights

Penicillin-susceptible and erythromycin-resistant Streptococcus pneumoniae strains are increasingly causing acute otitis media with acute mastoiditis in children. This study investigated these resistant Streptococcus pneumoniae isolates in Madrid.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pediatrics

Background:

  • Erythromycin resistance in Streptococcus pneumoniae typically correlates with penicillin resistance.
  • An emerging trend of penicillin-susceptible, erythromycin-resistant Streptococcus pneumoniae has been observed in pediatric acute otitis media cases complicated by acute mastoiditis.

Purpose of the Study:

  • To analyze the prevalence and characteristics of Streptococcus pneumoniae isolates exhibiting a penicillin-susceptible and erythromycin-resistant profile.
  • To investigate the clinical significance of this specific antibiotic resistance pattern in pediatric mastoiditis.

Main Methods:

  • Retrospective review of a microbiology database.
  • Analysis of Streptococcus pneumoniae isolates from patients with acute otitis media and acute mastoiditis.
  • Characterization of antibiotic susceptibility profiles, focusing on penicillin and erythromycin.

Main Results:

  • Identification of an increasing number of Streptococcus pneumoniae isolates with a distinct penicillin-susceptible and erythromycin-resistant phenotype.
  • These isolates were specifically associated with complicated acute otitis media cases leading to acute mastoiditis in children.

Conclusions:

  • The emergence of penicillin-susceptible, erythromycin-resistant Streptococcus pneumoniae poses a diagnostic and therapeutic challenge in pediatric mastoiditis.
  • Further research is needed to understand the mechanisms and epidemiological spread of this resistance pattern.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...